Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-03

Clinical Trial Update: REsiduAL rISk Under Intensive Lipid-lowering Therapy In Coronary Heart Disease

View source ↗

Summary

A clinical trial titled 'REsiduAL rISk Under Intensive Lipid-lowering Therapy In Coronary Heart Disease' is currently recruiting to evaluate intensive lipid-low…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Coronary Heart Disease (CHD) | Status: RECRUITING